Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies
Viracta Therapeutics, Inc.
Viracta Therapeutics, Inc.
Astex Pharmaceuticals, Inc.
Celgene
Takeda
AbbVie
Baylor College of Medicine
Amgen Research (Munich) GmbH
Seagen Inc.
Asan Medical Center